![](/images/general/no_picture/200_user.png)
Jeffery Shawn Zweizig
Examiner (ID: 11083, Phone: (571)272-1758 , Office: P/2842 )
Most Active Art Unit | 2816 |
Art Unit(s) | 2816, 2849, 2842, 2504 |
Total Applications | 2555 |
Issued Applications | 2334 |
Pending Applications | 90 |
Abandoned Applications | 130 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7619991
[patent_doc_number] => 06943192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-13
[patent_title] => 'Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate'
[patent_app_type] => utility
[patent_app_number] => 09/863035
[patent_app_country] => US
[patent_app_date] => 2001-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8960
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/943/06943192.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863035
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863035 | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | May 21, 2001 | Issued |
Array
(
[id] => 6896423
[patent_doc_number] => 20010027213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Use of pyrethroid compounds to promote hair growth'
[patent_app_type] => new
[patent_app_number] => 09/858929
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3963
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20010027213.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858929
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858929 | Use of pyrethroid compounds to promote hair growth | May 15, 2001 | Abandoned |
Array
(
[id] => 996627
[patent_doc_number] => 06914067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Compositions and methods for the treatment of colorectal cancer'
[patent_app_type] => utility
[patent_app_number] => 09/853619
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7862
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/914/06914067.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853619
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853619 | Compositions and methods for the treatment of colorectal cancer | May 13, 2001 | Issued |
Array
(
[id] => 6033512
[patent_doc_number] => 20020019399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Therapeutic agents for drug dependence'
[patent_app_type] => new
[patent_app_number] => 09/850431
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3086
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019399.pdf
[firstpage_image] =>[orig_patent_app_number] => 09850431
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/850431 | Therapeutic agents for drug dependence | May 6, 2001 | Issued |
Array
(
[id] => 6403364
[patent_doc_number] => 20020037327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Treatment for cancer and compounds for use therein'
[patent_app_type] => new
[patent_app_number] => 09/850524
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4964
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037327.pdf
[firstpage_image] =>[orig_patent_app_number] => 09850524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/850524 | Treatment for cancer and compounds for use therein | May 6, 2001 | Abandoned |
Array
(
[id] => 6409042
[patent_doc_number] => 20020037933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Management of septic shock'
[patent_app_type] => new
[patent_app_number] => 09/849591
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7703
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037933.pdf
[firstpage_image] =>[orig_patent_app_number] => 09849591
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/849591 | Management of septic shock | May 6, 2001 | Abandoned |
Array
(
[id] => 6476895
[patent_doc_number] => 20020022608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Use of tetracycline derivatives in treating multiple sclerosis'
[patent_app_type] => new
[patent_app_number] => 09/848139
[patent_app_country] => US
[patent_app_date] => 2001-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6109
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022608.pdf
[firstpage_image] =>[orig_patent_app_number] => 09848139
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/848139 | Use of tetracycline derivatives in treating multiple sclerosis | May 2, 2001 | Issued |
Array
(
[id] => 1164126
[patent_doc_number] => 06759397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Ginsenoside chemotherapy'
[patent_app_type] => B2
[patent_app_number] => 09/847155
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3218
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759397.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847155 | Ginsenoside chemotherapy | Apr 30, 2001 | Issued |
Array
(
[id] => 7368174
[patent_doc_number] => 20040092549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Methods and compositions for selective cancer chemotherapy'
[patent_app_type] => new
[patent_app_number] => 09/830912
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3395
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092549.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830912
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830912 | Methods and compositions for selective cancer chemotherapy | Apr 29, 2001 | Abandoned |
Array
(
[id] => 6016899
[patent_doc_number] => 20020103141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Antiangiogenic combination therapy for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 09/843132
[patent_app_country] => US
[patent_app_date] => 2001-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52837
[patent_no_of_claims] => 181
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103141.pdf
[firstpage_image] =>[orig_patent_app_number] => 09843132
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/843132 | Antiangiogenic combination therapy for the treatment of cancer | Apr 24, 2001 | Abandoned |
Array
(
[id] => 1467448
[patent_doc_number] => 06458840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-01
[patent_title] => 'Use of valproic acid analog for the treatment and prevention of migraine and affective illness'
[patent_app_type] => B2
[patent_app_number] => 09/840376
[patent_app_country] => US
[patent_app_date] => 2001-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8058
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458840.pdf
[firstpage_image] =>[orig_patent_app_number] => 09840376
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/840376 | Use of valproic acid analog for the treatment and prevention of migraine and affective illness | Apr 22, 2001 | Issued |
Array
(
[id] => 1440235
[patent_doc_number] => 06495517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-17
[patent_title] => 'Cyclooxygenase inhibitor'
[patent_app_type] => B2
[patent_app_number] => 09/838125
[patent_app_country] => US
[patent_app_date] => 2001-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2598
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495517.pdf
[firstpage_image] =>[orig_patent_app_number] => 09838125
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/838125 | Cyclooxygenase inhibitor | Apr 19, 2001 | Issued |
Array
(
[id] => 6886767
[patent_doc_number] => 20010020036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-06
[patent_title] => '5HT1 receptor agonists and metoclopramide for the treatment of migraine'
[patent_app_type] => new
[patent_app_number] => 09/838440
[patent_app_country] => US
[patent_app_date] => 2001-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4247
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20010020036.pdf
[firstpage_image] =>[orig_patent_app_number] => 09838440
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/838440 | 5HT1 receptor agonists and metoclopramide for the treatment of migraine | Apr 18, 2001 | Abandoned |
Array
(
[id] => 6921778
[patent_doc_number] => 20010029263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'Novel pyrrolidine carboxylate hair revitalizing agents'
[patent_app_type] => new
[patent_app_number] => 09/825896
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5282
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029263.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825896 | Novel pyrrolidine carboxylate hair revitalizing agents | Apr 4, 2001 | Abandoned |
Array
(
[id] => 6477237
[patent_doc_number] => 20020022627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Inhibition of cyclooxygenase-2activity'
[patent_app_type] => new
[patent_app_number] => 09/823057
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2347
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022627.pdf
[firstpage_image] =>[orig_patent_app_number] => 09823057
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/823057 | Inhibition of cyclooxygenase-2activity | Mar 29, 2001 | Abandoned |
Array
(
[id] => 6000715
[patent_doc_number] => 20020028845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => '6-methoxy-2-naphthylacetic acid prodrugs'
[patent_app_type] => new
[patent_app_number] => 09/823000
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9045
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028845.pdf
[firstpage_image] =>[orig_patent_app_number] => 09823000
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/823000 | 6-methoxy-2-naphthylacetic acid prodrugs | Mar 29, 2001 | Issued |
Array
(
[id] => 6225365
[patent_doc_number] => 20020004500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Vasopeptidase Inhibitors to treat isolated systolic hypertension'
[patent_app_type] => new
[patent_app_number] => 09/819549
[patent_app_country] => US
[patent_app_date] => 2001-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1976
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004500.pdf
[firstpage_image] =>[orig_patent_app_number] => 09819549
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/819549 | Vasopeptidase Inhibitors to treat isolated systolic hypertension | Mar 27, 2001 | Abandoned |
Array
(
[id] => 1046885
[patent_doc_number] => 06864280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-08
[patent_title] => 'γ-Tocotrienol-containing diuretics'
[patent_app_type] => utility
[patent_app_number] => 10/239945
[patent_app_country] => US
[patent_app_date] => 2001-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 2567
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239945 | γ-Tocotrienol-containing diuretics | Mar 26, 2001 | Issued |
Array
(
[id] => 7015122
[patent_doc_number] => 20010051624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-13
[patent_title] => 'Method and compositions for the treatment of allergic conditions using PGD2 receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 09/818885
[patent_app_country] => US
[patent_app_date] => 2001-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8016
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20010051624.pdf
[firstpage_image] =>[orig_patent_app_number] => 09818885
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/818885 | Method and compositions for the treatment of allergic conditions using PGD2 receptor antagonists | Mar 26, 2001 | Abandoned |
Array
(
[id] => 6546596
[patent_doc_number] => 20020137787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitus'
[patent_app_type] => new
[patent_app_number] => 09/812410
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2368
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137787.pdf
[firstpage_image] =>[orig_patent_app_number] => 09812410
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/812410 | Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitus | Mar 20, 2001 | Abandoned |